Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Healthcare

Inovio Gets $71 Million From U.S. Defense Dept For COVID-19 Vaccine Device

Inovio said a previous version of the device has been used in clinical trials to safely dose more than 2,000 patients

Read More

Cipla To Price Remdesivir Version For COVID-19 Under 5,000 Rupees

The expectations suggest sales of between $2 billion and $3 billion between 2020 and 2021 at a price of $1,000 to $2,000 per course, according to Jefferies analyst Michael Yee.

Read More

Pig Trial Of AstraZeneca's COVID-19 Vaccine Shows Promise With Two Shots

The researchers saw a marked increase in neutralising antibodies, which bind to the virus in a way that blocks infection," the Pirbright team said in a statement.

Read More

Sanofi Eyes Approval Of COVID-19 Vaccine By First Half Of 2021

There are currently no vaccines to prevent the coronavirus that has infected more than 9 million people and killed over 469,000 globally, and only a couple of medicines that have demonstrated benefit in hospitalized COVID-19 patients in clinical trials.

Read More

Sanofi Eyes Approval Of COVID-19 Vaccine By First Half Of 2021

Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the second half of 2021.

Read More

Gilead Targets Remdesivir Supply For Two Million COVID-19 Patients By Year-End

Gilead's expectations of two million treatment courses suggests sales of between $2 billion and $3 billion between 2020 and 2021 at a price of $1,000 to $2,000 per course

Read More

GSK In Quest To Be Best, Not First, In Race For COVID-19 Vaccine

GSK is one of more than 100 global players working on vaccines against COVID-19, which has killed about 350,000 people.

Read More

Alembic Pharma Gets EIR From USFDA For Its Panelav Facility

Shares of Alembic Pharmaceuticals were trading at Rs 940.05 per scrip on the BSE, up 3.50 per cent from its previous close.

Read More

Glenmark Pharmaceuticals Gets USFDA Nod For Fingolimod Capsules

Shares of Glenmark Pharmaceuticals were trading at Rs 411.20 a piece on BSE in morning trade, up 1.44 per cent from their previous close.

Read More

Dexamethasone: Is This Drug Saving Covid-19 Patients?

The report by Oxford University stated the recovery of more than 11,500 patients, enrolling in over 175 hospitals across the UK.

Read More

France Expects AstraZeneca COVID-19 Vaccine To Be Shared Pro Rata

The British drugmaker signed a contract with European governments at the weekend to supply the region with up to 400 million doses of its potential vaccine.

Read More

COVID-19 Cure Possible Through Ayurveda, Patanjali Case Study Showed 100 % Favorable Results, Claims Acharya Balkrishna

India's COVID-19 tally on Saturday witnessed its highest-ever spike of 11,458 cases, according to the Union Ministry of Health and Family Welfare (MoHFW).

Read More

India Lifts Export Ban On Trump-Touted Drug Hydroxychloroquine

Manufacturers, except export-oriented units and those in special economic zones, would still have to supply 20% of their production to the domestic market,

Read More

Indian Firm Panacea Says Aiming To Make COVID-19 Vaccine

Panacea's shares jumped 20% in morning trading on India's National Stock Exchange after the news.

Read More

AstraZeneca Wins Fresh US Backing In Race For COVID-19 Treatment

Companies and governments are scrambling to bring a solution for the illness caused by the new coronavirus to market as soon as possible

Read More